Long-Term Safety of Pembrolizumab Monotherapy and Relationship With Clinical Outcome
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Long-Term Safety of Pembrolizumab Monotherapy and Relationship With Clinical Outcome: A Landmark Analysis in Patients With Advanced Melanoma
Eur. J. Cancer 2020 Dec 23;144(xx)182-191, C Robert, WJ Hwu, O Hamid, A Ribas, JS Weber, AI Daud, FS Hodi, JD Wolchok, TC Mitchell, P Hersey, R Dronca, RW Joseph, C Boutros, L Min, GV Long, J Schachter, I Puzanov, R Dummer, J Lin, N Ibrahim, SJ Diede, MS Carlino, AM JoshuaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.